Effects of prostaglandin D2 on perinatal circulation.

Prostaglandin D2 (PGD2) is a powerful antiaggregatory agent and contracts various types of smooth muscle preparations, including isolated canine and bovine pulmonary vessels. Pulmonary vascular responses of anesthetized fetal and adult goats and newborn lambs to PGD2 were evaluated in situ by means of an isolated perfused lower left lobe preparation. These experiments indicate that PGD2 is a pulmonary vasodilator in fetal goats, both a pulmonary vasodilator and vasoconstrictor in newborn lambs depending on the dose used, and a pulmonary vasoconstrictor in adult goats. Evidence is presented of an age-related change in pulmonary vascular response to prostaglandins. The responses of the pulmonary vasculature are dose dependent; however, there is not a significant dose-dependent relationship for systemic arterial pressure or heart rate with intrapulmonary infusions of PGD2. The inhibition of prostaglandin synthesis potentiates the pulmonary response to PGD2 in fetal goats. In contrast with other prostaglandins, PGI2, PGE2, and PGE1, which dilate both the fetal pulmonary and systemic circulations, PGD2 has minimal action on the systemic circulation over a wide range of doses.

[1]  J. Lock,et al.  Direct pulmonary vascular responses to prostaglandins in the conscious newborn lamb. , 1980, The American journal of physiology.

[2]  J. Fletcher,et al.  Hemodynamic evaluation of prostaglandin D2 in the conscious baboon. , 1980, Advances in prostaglandin and thromboxane research.

[3]  C. Leffler,et al.  Pulmonary and systemic vascular responses of perinatal goats to prostaglandins E1 and E2. , 1979, The American journal of physiology.

[4]  J. Oates,et al.  Metabolism of prostaglandin D2 in the monkey. , 1979, The Journal of biological chemistry.

[5]  P. Kadowitz,et al.  Effects of arachidonic acid and prostaglandins on lung function in the intact dog. , 1978, Journal of applied physiology: respiratory, environmental and exercise physiology.

[6]  L. Feigen,et al.  Comparative effects of arachidonic acid, bisenoic prostaglandins, and an endoperoxide analog on the canine pulmonary vascular bed. , 1977, Canadian journal of physiology and pharmacology.

[7]  M. Wasserman,et al.  Bronchopulmonary and cardiovascular effects of prostaglandin D2 in the dog. , 1977, Prostaglandins.

[8]  C. Leffler,et al.  Effects of prostaglandin precursors, prostaglandins, and prostaglandin metabolites on pulmonary circulation of perinatal goats. , 1977, Chest.

[9]  W. Schlegel,et al.  Prostaglandin endoperoxide analogues and prostaglandin D2 as substrates of human placental 15‐hydroxy prostaglandin dehydrogenase , 1976, FEBS letters.

[10]  Jones Rl Cardiovascular actions of prostaglandins D and E in the sheep: evidence for two distinct receptors. , 1976 .

[11]  F. Sun,et al.  Studies on 15-hydroxyprostaglandin dehydrogenase from monkey lung. , 1976, Advances in prostaglandin and thromboxane research.

[12]  P. Kadowitz,et al.  Effect of prostaglandin E2 on pulmonary vascular resistance in intact dog, swine and lamb. , 1975, European journal of pharmacology.

[13]  M. Hamberg,et al.  Prostaglandin endoperoxides IV. Effects on smooth muscle. , 1975, Life sciences.

[14]  C. Hensby The enzymatic conversion of prostaglandin D2 to prostaglandin F2 alpha. , 1974, Prostaglandins.

[15]  R. Flower Drugs which inhibit prostaglandin biosynthesis. , 1974, Pharmacological reviews.

[16]  D. Nugteren,et al.  Isolation and properties of intermediates in prostaglandin biosynthesis. , 1973, Biochimica et biophysica acta.